Stone House Investment Management »

Cytek Biosciences shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4k 318 4.37

More positions owned by Stone House Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Univrsl Usd (IUSB)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr S&p 500 Grwt Etf (IVW)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Core Msci Emkt (IEMG)
Procter & Gamble Company (PG)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Fidelity Covington Trust Enhanced Intl (FENI)
Blackrock Etf Trust Ishares A I Inno (BAI)
Ishares Tr Msci Usa Mmentm (MTUM)

View all positions for Stone House Investment Management

Top funds holding Cytek Biosciences

BlackRock
Vanguard Group
Hillhouse Capital Advisors
Millennium Management
Robeco Investment Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Goldman Sachs Group
Vanguard Portfolio Management
Morgan Stanley
Royce & Associates
Brown Capital Management
Russell Investments

View all funds holding Cytek Biosciences